KO-539

Kura Oncology Provides Update on Phase 1b Study of KO-539 in Acute Myeloid Leukemia
BioSpace
Wed, 11/24/21 - 10:14 am
Kura Oncology
KOMET-001
KO-539
AML
patient deaths